A day after getting emergency use authorisation from Indian drug regulator for its Covid vaccine, Zydus Group MD on Saturday mentioned readability on the worth of ZyCov-D will emerge subsequent week.

“Next week will have clarity on the price of the ZyCOV-D vaccine. The supply of vaccines will start in mid-September. We can scale up production of vaccines to 1 crore a month from October at the new production plant,” mentioned Dr. Sharvil Patel, MD, Zydus Group.

“The efficacy of our Covid-19 vaccine is over 66%, and its efficacy against the Delta variant is about 66%,” added Patel.

ZyCov-D is a three-dose vaccine given on day zero, day 28 after which on day 56. This vaccine is accepted for adults and adolescents above the age of 12, he mentioned.

ZyCov-D is the world’s first DNA-based vaccine in opposition to the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which performs a significant position in safety from the illness in addition to viral clearance, it mentioned.

The authorities’s Department of Biotechnology (DBT) additionally mentioned that the “plug-and-play” expertise on which the plasmid DNA platform relies could be simply tailored to take care of mutations within the virus, akin to these already occurring.

“Zydus Cadila has received approval for Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D today i.e. 20/08/2021, the world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above,” it mentioned.

“India is fighting COVID-19 with full vigour. The approval for world’s first DNA based ‘ZyCov-D’ vaccine of @ZydusUniverse is a testimony to the innovative zeal of India’s scientists,” Prime Minister Modi tweeted on Friday.

“A momentous feat indeed,” he added.

Vaccines Covishield, Covaxin and Sputnik V are being given to solely these above 18 years of age and in contrast to ZyCoV-D, which is three-dose, these are administered in two doses.

LEAVE A REPLY

Please enter your comment!
Please enter your name here